Ignite Creation Date:
2024-05-05 @ 12:08 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00258297
Status:
TERMINATED
Last Update Posted:
2013-10-16
First Post:
2005-11-22
Brief Title:
Gefitinib in Treating Patients With Stage I Stage II or Stage III Esophageal Cancer That Can Be Removed By Surgery
Organization:
University of Rochester